Workflow
NexGel(NXGL) - 2024 Q3 - Quarterly Report
NXGLNexGel(NXGL)2024-11-13 22:29

Revenue Growth - Revenues for the three months ended September 30, 2024 increased by 140.8% to 2,940thousandcomparedto2,940 thousand compared to 1,221 thousand in the same period in 2023, driven by growth in branded consumer products, including 1,373thousandfromSillyGeorge[168]RevenuesfortheninemonthsendedSeptember30,2024increasedby87.81,373 thousand from Silly George[168] - Revenues for the nine months ended September 30, 2024 increased by 87.8% to 5,647 thousand compared to 3,007thousandinthesameperiodin2023,with3,007 thousand in the same period in 2023, with 1,753 thousand contributed by Silly George since its acquisition on May 15, 2024[184] Gross Profit and Margin - Gross profit for the three months ended September 30, 2024 increased to 1,282thousand,upfrom1,282 thousand, up from 344 thousand in the same period in 2023, with gross profit margin improving to 43.6% from 28.2%[174] - Gross profit increased by 1,508millionto1,508 million to 1,969 million for the nine months ended September 30, 2024, compared to 461millionforthesameperiodin2023,drivenbybrandedconsumerproducts[185]Grossprofitmarginimprovedto34.9461 million for the same period in 2023, driven by branded consumer products[185] - Gross profit margin improved to 34.9% for the nine months ended September 30, 2024, up from 15.3% in the same period in 2023[185] Cost of Revenues - Cost of revenues for the three months ended September 30, 2024 increased by 89.1% to 1,658 thousand, primarily due to higher sales of branded consumer products, including Silly George and Kenkoderm[175] - Cost of revenues increased by 1,132million(44.51,132 million (44.5%) to 3,678 million for the nine months ended September 30, 2024, primarily due to higher materials and finished products costs[187] Selling, General, and Administrative Expenses - Selling, general and administrative expenses for the three months ended September 30, 2024 increased by 117.9% to 2,070thousand,drivenbyhigheradvertising,marketing,andAmazonfees,whichincreasedby460.12,070 thousand, driven by higher advertising, marketing, and Amazon fees, which increased by 460.1% to 997 thousand[177][180] - Selling, general, and administrative expenses increased by 1,975million(75.11,975 million (75.1%) to 4,604 million for the nine months ended September 30, 2024, driven by higher advertising, marketing, and Amazon fees[188] - Advertising, marketing, and Amazon fees increased by 1,255million(286.51,255 million (286.5%) to 1,693 million for the nine months ended September 30, 2024, due to promoting Kenkoderm and Silly George[191] Research and Development Expenses - Research and development expenses decreased to 0forthethreemonthsendedSeptember30,2024,comparedto0 for the three months ended September 30, 2024, compared to 6 thousand in the same period in 2023, as the company focused on existing products[184] - Research and development expenses decreased by 12million(13.312 million (13.3%) to 78 million for the nine months ended September 30, 2024[196] Acquisitions and Joint Ventures - The company expanded its product portfolio in December 2023 with the acquisition of Kenkoderm, a skincare line focused on psoriasis, marking its first venture into products unrelated to its core gel technology[164] - In May 2024, the company acquired Silly George, a beauty and cosmetics brand, further diversifying its retail sales presence beyond its core gel technology[165] - The company formed a joint venture on March 1, 2023, acquiring a 50% interest in a converting and packaging business, expanding its capacity to offer a variety of gel shapes and sizes[163][166] - The company entered into another joint venture on January 6, 2023, acquiring a 50% interest to pursue branded consumer product retail opportunities and develop new patch products[166] Cash Flow and Financial Position - Net cash used in operating activities was 3,008millionfortheninemonthsendedSeptember30,2024,comparedto3,008 million for the nine months ended September 30, 2024, compared to 2,649 million for the same period in 2023[197] - The company had 1,059millionincashandcashequivalentsasofSeptember30,2024,downfrom1,059 million in cash and cash equivalents as of September 30, 2024, down from 2,700 million at December 31, 2023[197] Future Plans and Expectations - The company plans to explore new product channel sales in consumer products, such as cosmetics, athletic products, and proprietary medical devices[202] - The company expects to continue incurring losses in the near-term future and may consider raising capital through equity or debt offerings to fund potential acquisitions[204]